Skip to content

TO SEE HOW EFFECTIVELY TWO PAIN RELIEVING AGENTS ACT TO REDUCE PAIN WHILE SECURING CANNULA IN CHILDREN

A COMPARATIVE STUDY OF EFFECTIVENESS OF VAPOCOOLANT SPRAY AND EMLA CREAM IN REDUCING PAIN DURING INTRAVENOUS CANNULATION IN PAEDIATRIC POPULATION - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/07/069941
Enrollment
104
Registered
2024-07-04
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: VAPOCOOLANT SPRAY: EUTECTIC MIXTURE OF LOCAL ANAESTHETICS CREAM Control Intervention1: NIL: NIL

Sponsors

HAREESH BABU
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Children aged between 6-18 years undergoing elective surgeries requiring intravenous cannulation

Exclusion criteria

Exclusion criteria: 1. Children undergoing emergency surgeries 2. Children with difficult cannulation 3. Children with failed cannulation in the designated site 4. Children with burns, broken or infected skin 5. Children with intellectual disabilities 6. History of allergy to local anaesthetics

Design outcomes

Primary

MeasureTime frame
To compare efficacy of vapocoolant spray and EMLA cream in terms of pain score using Wong-Baker faces pain rating scaleTimepoint: At 2 minutes

Secondary

MeasureTime frame
To compare the ease of cannulation, hemodynamic changes, occurrence of adverse effects & cost analysis between two groupsTimepoint: 1. Number of attempts- 0 minutes 2. Hemodynamic changes- At baseline, 2 minutes, 4 minutes, 8 minutes, 10 minutes 4. Occurrence of adverse effects such as erythema, edema, bruise, pallor, pruritus- At 20 minutes, 40 minutes, 60 minutes

Countries

India

Contacts

Public ContactDR PRIYANKA P V

K S HEGDE MEDICAL ACADEMY

gaibhat@gmail.com9448467181

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026